Dariohealth Corp. current report, 27 May 2014

Business Context and Reporting Period

This Form 8-K is a Current Report filed by LabStyle Innovations Corp. (not Dariohealth Corp.) on May 29, 2014, regarding events occurring on May 27, 2014. The company is incorporated in Delaware and headquartered in Caesarea Industrial Park, Israel. The filing addresses a resignation from the Board of Directors and subsequent changes to the 2014 Annual Meeting of Stockholders.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial statements or performance data.

Material Changes

  • Board Resignation: Dr. David Weintraub resigned from the Board of Directors on May 27, 2014, for personal reasons.
  • Proxy Statement Revision: The Board withdrew Dr. Weintraub's name from nomination as a director via unanimous written consent on May 28, 2014.
  • Meeting Date Change: The date of the 2014 Annual Meeting of Stockholders was revised from June 10, 2014, to June 17, 2014.
  • Regulatory Status: The Company does not have securities registered under Section 12 of the Exchange Act and is not subject to standard proxy filing requirements under Section 14.

Guidance, Outlook, and Risks

The filing includes a standard Cautionary Note Regarding Forward-Looking Statements. It warns that actual results may differ materially from any forward-looking statements due to various risks discussed in other SEC filings. The Company explicitly states it undertakes no obligation to update these statements. No specific financial guidance or management commentary on business operations is provided in this document.

Investor Verification Checklist

  • Verify the current composition of the Board of Directors following Dr. Weintraub's resignation.
  • Confirm the revised date of the Annual Meeting (June 17, 2014) and the updated proxy statement (Exhibit 99.1).
  • Review the Company's other SEC filings to understand the specific risks mentioned in the forward-looking statement disclaimer.
  • Note the discrepancy between the requested company name (Dariohealth Corp.) and the actual registrant (LabStyle Innovations Corp.).